Pregnitude is a reproductive dietary supplement that helps support ovulatory function, regular menstrual cycles and quality of eggs for women.
One Month Supply with 60 Packets of Pregnitude
Pregnitude is a natural dietary supplement that contains 2 grams of myo-inositol, as well as 200 mcg of folic acid.
- Myo-inositol is a naturally occurring substance produced by the human body from glucose. It belongs to the vitamin B complex group.
- Folic acid is a B vitamin that promotes cell growth.
How to take Pregnitude
- Carefully separate the two packets of Pregnitude from each other along the perforated line.
- Tear the packet open and pour contents into a glass.
- With the contents at the bottom of your glass, fill your glass with water.
- Once the glass is full, mix the powder by stirring until dissolved.
- Drink the entire glass, and take one packet in the morning and one packet in the evening every day.
It is important to discuss the use of all medications, vitamins and supplements with your
High doses of Myo-inositol may have additive effects when taken concurrently with selective
serotonin reuptake inhibitor (SSRI) and selective serotonin norepinephrine reuptake
inhibitor (SNRI) antidepressant medications.
You should use caution when combining high doses of Myo-inositol with herbal products
like St. Johnís Wort.
High doses of Folic acid may result in decreased serum levels of the anticonvulsant drugs.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
There have been many scientific studies investigating the effects of supplementing with Myo-inositol in women with PCOS (Polycystic Ovary Syndrome).
The conculsions typically show that the myo-inositol is helpful in inducing ovulation for women with PCOS and also helps improve the quality of the eggs.
This study's results showed that 88% of the study participants had at least one normal menstrual cycle and 72% of those women maintained normal ovulation, after the study. 40% of study participants achieved pregnancy during the 6 month study.
Papaleo E, Unfer V, Baillargeon JP, De Santis L, Fusi F, Brigante C, Marelli G, Cino I, Redaelli A, Ferrari A. Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecol Endocrinol. 2007 Dec;23(12):700-3. Epub 2007 Oct 10. PubMed PMID: 17952759.
This study showed that plasma levels of insulin, LH and FSH were significantly reduced after 12 weeks of continued usage of myo-inositol. Insulin sensitivity was also significantly improved. For the PCOS patients who had no period or very irregular menstrual periods, menstrual cycles were restored by the end of the 12 weeks.
Artini PG, Di Berardino OM, Papini F, Genazzani AD, Simi G, Ruggiero M, Cela V. Endocrine and clinical effects of myo-inositol administration in policystyc ovary syndrome. A randomized study. Gynecol Endocrinol. 2013 Jan 22. [Epub ahead of print] PubMed PMID: 23336594.
In a comparison of myo-inositol and
D-chiro-inositol, this study showed that only myo-inositol was able to improve oocyte and embryo quality.
Galletta M, Grasso S, Vaiarelli A, Roseff SJ. Bye-bye chiro-inositol - myo-inositol: true progress in the treatment of polycystic ovary syndrome and ovulation induction. Eur Rev Med Pharmacol Sci. 2011 Oct;15(10):1212-4. PubMed PMID: 22165685.
"These data suggest that myoinositol may be useful in the treatment of
PCOS patients undergoing ovulation induction, both for its
insulin-sensitizing activity, and its role in oocyte maturation."
Ciotta L, Stracquadanio M, Pagano I, Carbonaro A, Palumbo M, Gulino F. Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial. Eur Rev Med Pharmacol Sci. 2011 May;15(5):509-14. PubMed PMID: 21744744.